| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sphingolipid binding | 2.53e-04 | 34 | 14 | 2 | GO:0046625 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.00e-04 | 37 | 14 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.58e-03 | 85 | 14 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.47e-03 | 127 | 14 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 5.32e-03 | 158 | 14 | 2 | GO:0004386 | |
| GeneOntologyMolecularFunction | integrin binding | 6.48e-03 | 175 | 14 | 2 | GO:0005178 | |
| GeneOntologyCellularComponent | tenascin complex | 2.50e-06 | 4 | 14 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 5.63e-05 | 17 | 14 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 6.97e-04 | 59 | 14 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.79e-03 | 530 | 14 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | cell surface | 5.17e-03 | 1111 | 14 | 4 | GO:0009986 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.65e-03 | 656 | 14 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.72e-03 | 658 | 14 | 3 | GO:0030312 | |
| Domain | - | 6.72e-07 | 24 | 14 | 3 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 6.72e-07 | 24 | 14 | 3 | IPR014715 | |
| Domain | Fibrinogen_C | 9.70e-07 | 27 | 14 | 3 | PF00147 | |
| Domain | FBG | 1.21e-06 | 29 | 14 | 3 | SM00186 | |
| Domain | - | 1.35e-06 | 30 | 14 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.35e-06 | 30 | 14 | 3 | IPR014716 | |
| Domain | DUF4208 | 1.56e-06 | 3 | 14 | 2 | IPR025260 | |
| Domain | DUF4208 | 1.56e-06 | 3 | 14 | 2 | PF13907 | |
| Domain | DUF4208 | 1.56e-06 | 3 | 14 | 2 | SM01176 | |
| Domain | FIBRINOGEN_C_2 | 1.64e-06 | 32 | 14 | 3 | PS51406 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.64e-06 | 32 | 14 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_1 | 1.64e-06 | 32 | 14 | 3 | PS00514 | |
| Domain | EGF_extracell | 1.12e-05 | 60 | 14 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.12e-05 | 60 | 14 | 3 | PF07974 | |
| Domain | EGF | 2.21e-05 | 235 | 14 | 4 | SM00181 | |
| Domain | EGF_3 | 2.21e-05 | 235 | 14 | 4 | PS50026 | |
| Domain | EGF-like_dom | 2.78e-05 | 249 | 14 | 4 | IPR000742 | |
| Domain | EGF_1 | 3.05e-05 | 255 | 14 | 4 | PS00022 | |
| Domain | EGF-like_CS | 3.34e-05 | 261 | 14 | 4 | IPR013032 | |
| Domain | EGF_2 | 3.55e-05 | 265 | 14 | 4 | PS01186 | |
| Domain | Chromodomain_CS | 7.93e-05 | 18 | 14 | 2 | IPR023779 | |
| Domain | Fibrinogen_CS | 8.86e-05 | 19 | 14 | 2 | IPR020837 | |
| Domain | Chromo_domain | 1.43e-04 | 24 | 14 | 2 | IPR023780 | |
| Domain | Chromo | 1.68e-04 | 26 | 14 | 2 | PF00385 | |
| Domain | Growth_fac_rcpt_ | 1.94e-04 | 156 | 14 | 3 | IPR009030 | |
| Domain | CHROMO_2 | 1.95e-04 | 28 | 14 | 2 | PS50013 | |
| Domain | CHROMO_1 | 1.95e-04 | 28 | 14 | 2 | PS00598 | |
| Domain | SNF2_N | 2.55e-04 | 32 | 14 | 2 | PF00176 | |
| Domain | SNF2_N | 2.55e-04 | 32 | 14 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 2.55e-04 | 32 | 14 | 2 | IPR016197 | |
| Domain | CHROMO | 2.72e-04 | 33 | 14 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.72e-04 | 33 | 14 | 2 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.06e-04 | 35 | 14 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 3.61e-04 | 38 | 14 | 2 | PS00690 | |
| Domain | EGF_Ca-bd_CS | 2.33e-03 | 97 | 14 | 2 | IPR018097 | |
| Domain | EGF_CA | 2.43e-03 | 99 | 14 | 2 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.78e-03 | 106 | 14 | 2 | IPR000152 | |
| Domain | Helicase_C | 2.83e-03 | 107 | 14 | 2 | PF00271 | |
| Domain | HELICc | 2.83e-03 | 107 | 14 | 2 | SM00490 | |
| Domain | Helicase_C | 2.88e-03 | 108 | 14 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 2.93e-03 | 109 | 14 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.93e-03 | 109 | 14 | 2 | PS51192 | |
| Domain | DEXDc | 2.93e-03 | 109 | 14 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.99e-03 | 110 | 14 | 2 | IPR014001 | |
| Domain | EGF_CA | 3.66e-03 | 122 | 14 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.78e-03 | 124 | 14 | 2 | IPR001881 | |
| Domain | EGF | 3.90e-03 | 126 | 14 | 2 | PF00008 | |
| Domain | fn3 | 6.35e-03 | 162 | 14 | 2 | PF00041 | |
| Domain | FN3 | 8.21e-03 | 185 | 14 | 2 | SM00060 | |
| Domain | FN3 | 9.45e-03 | 199 | 14 | 2 | PS50853 | |
| Domain | FN3_dom | 1.04e-02 | 209 | 14 | 2 | IPR003961 | |
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 1.50e-07 | 2 | 14 | 2 | 25297984 | |
| Pubmed | CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage. | 4.51e-07 | 3 | 14 | 2 | 33022763 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 9326634 | ||
| Pubmed | 1.06e-04 | 653 | 14 | 4 | 22586326 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 1.16e-03 | 167 | 14 | 2 | chr1q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 5.05e-03 | 353 | 14 | 2 | chr12p13 | |
| GeneFamily | Fibrinogen C domain containing | 3.83e-07 | 25 | 11 | 3 | 554 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.17e-04 | 27 | 11 | 2 | 1253 | |
| GeneFamily | Fibronectin type III domain containing | 4.06e-03 | 160 | 11 | 2 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.29e-02 | 394 | 11 | 2 | 471 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 9.92e-05 | 174 | 14 | 3 | M39126 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.31e-04 | 191 | 14 | 3 | MM17059 | |
| Coexpression | NABA_MATRISOME | 1.36e-04 | 1026 | 14 | 5 | M5889 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 1.41e-04 | 196 | 14 | 3 | M4928 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.41e-04 | 196 | 14 | 3 | M3008 | |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_UP | 1.48e-04 | 199 | 14 | 3 | M6289 | |
| Coexpression | AIZARANI_LIVER_C6_KUPFFER_CELLS_2 | 2.20e-04 | 228 | 14 | 3 | M39110 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 3.24e-04 | 260 | 14 | 3 | M41075 | |
| Coexpression | NABA_CORE_MATRISOME | 3.62e-04 | 270 | 14 | 3 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.82e-04 | 275 | 14 | 3 | M5884 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.80e-07 | 187 | 14 | 4 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 153 | 14 | 3 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 153 | 14 | 3 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 153 | 14 | 3 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 157 | 14 | 3 | 4862a11ab8df27d26b4f1c1785e544a2d5b6db6e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 157 | 14 | 3 | a0ec1628ce29841889f1d9d4ee9422921af7b0b5 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 157 | 14 | 3 | c8f516d3f5622202d3f8514f68614cd86ea3f667 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 14 | 3 | 5f23173ec624ea7f893d22e326446f0e39e30b4e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 14 | 3 | becb8f726b84509ec29c75b530a3fe757651301d | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 14 | 3 | 1760ec2ac8913a2b33f46672a3f39ca7489966b8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 14 | 3 | ae8dd9c00f96590f27ed21cd6314f4577e00e312 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 14 | 3 | 518ee34c18065100a2f2c6e407d3a7866b908593 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 14 | 3 | c2fc76feff58d77128f5a5318fed9c265574d760 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 166 | 14 | 3 | 5126d8f02314717eed341d867856fd4fe16c5118 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 166 | 14 | 3 | 3037bdca38c3a65eacfa644219cc43c54e303749 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 170 | 14 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-05 | 171 | 14 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 172 | 14 | 3 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 172 | 14 | 3 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 173 | 14 | 3 | a664dbd7fb55b1c4309fa5f9425bc83924dac545 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 173 | 14 | 3 | 9a8fec9a08bb61456a4ea43ae1316bd3e197a773 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 173 | 14 | 3 | 054f64462b648ba6b4b28b48c716dc01b2ddd790 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 176 | 14 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | Monocytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-05 | 176 | 14 | 3 | 5b5f8655b0c6c56f98f70bce13e71f017d4b75a5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 176 | 14 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.11e-05 | 177 | 14 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.53e-05 | 188 | 14 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.57e-05 | 189 | 14 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 2.61e-05 | 190 | 14 | 3 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-05 | 191 | 14 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.69e-05 | 192 | 14 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-05 | 192 | 14 | 3 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.77e-05 | 194 | 14 | 3 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.77e-05 | 194 | 14 | 3 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.77e-05 | 194 | 14 | 3 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 195 | 14 | 3 | bad7f2162000f29488b3c4b903dcac9a818621f7 | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.86e-05 | 196 | 14 | 3 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 196 | 14 | 3 | a1b21f4667c05e837a1229cc5934db805ad562c5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 196 | 14 | 3 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 196 | 14 | 3 | 555c9e443fe3b9893cb320b78d84002e1f8c1701 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-05 | 196 | 14 | 3 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 2.86e-05 | 196 | 14 | 3 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 197 | 14 | 3 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-05 | 197 | 14 | 3 | 340ce4fef244176fb52e38ffbcbdfda5ac3467dd | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.90e-05 | 197 | 14 | 3 | dcce1c3dc5f3e53c368f758eb0fd5afcd86325e7 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 197 | 14 | 3 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-05 | 197 | 14 | 3 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 198 | 14 | 3 | c288b29287a562460d8970264e1833801590da73 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.95e-05 | 198 | 14 | 3 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 14 | 3 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.04e-05 | 200 | 14 | 3 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Caecum-(4)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 3.04e-05 | 200 | 14 | 3 | 6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.04e-05 | 200 | 14 | 3 | 59b2ebb69699c9bebf8c2697eb678fdccd0a998c | |
| ToppCell | Caecum-Monocyte-Monocyte|Caecum / Region, Cell class and subclass | 3.04e-05 | 200 | 14 | 3 | d33619b6c721eae3ebe50fba6b9d31fa99f2248f | |
| ToppCell | Caecum-Monocyte|Caecum / Region, Cell class and subclass | 3.04e-05 | 200 | 14 | 3 | 9e8d38d024a315512521b349e8ac7caa56219daf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-05 | 200 | 14 | 3 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.04e-05 | 200 | 14 | 3 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | Caecum-(4)_Monocyte-(40)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 3.04e-05 | 200 | 14 | 3 | b078058efc51f0ff4d92123b712933b32824c655 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-05 | 200 | 14 | 3 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-04 | 93 | 14 | 2 | 613c827a643a7b6d70ef932cfa1762e90bc5a338 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-04 | 93 | 14 | 2 | d102a0a015a2866e3fe549ac8796b9a0d5923d7e | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-04 | 93 | 14 | 2 | 0967a93dcc72d2d8f12d56de186ec1af55c36001 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-04 | 93 | 14 | 2 | 1a112bd4e5e63826efad0338ce99d7a7ad9c72b9 | |
| ToppCell | Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-04 | 93 | 14 | 2 | 9c566fc2a8c7630bea28e8e46df55454aa409bc1 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-04 | 102 | 14 | 2 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-04 | 102 | 14 | 2 | 9392288e284b71f3a208d9f283e6e3c944b7dd10 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-04 | 102 | 14 | 2 | c58e09aaa11b664c7d99e91f903561fa18460f05 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-04 | 102 | 14 | 2 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-04 | 102 | 14 | 2 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.38e-04 | 111 | 14 | 2 | 567e5ac2c78d45db207067f0f152bb24ed048c50 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.38e-04 | 111 | 14 | 2 | d1ec8e8e9adb11511b4ef363cc6f99286e2cc842 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.38e-04 | 111 | 14 | 2 | fd7aa25e83a0d762969e3966a658652da40c490e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.38e-04 | 111 | 14 | 2 | d48561078c387ac856c1c30e3d7a3e75ebde942e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.38e-04 | 111 | 14 | 2 | a1b7940c6fa0e5a58aa4798b604469d79f33fa44 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.48e-04 | 112 | 14 | 2 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 6.29e-04 | 120 | 14 | 2 | e17c85d41c781a29dec7e03a8b0637dccb4346bc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-04 | 124 | 14 | 2 | e9b6fdac2bef4bf1fee6a486f4628b68adc80f57 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-04 | 128 | 14 | 2 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.37e-04 | 130 | 14 | 2 | 3a0846b74ba34bd0e2a05b4f1f39f3940df93780 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.60e-04 | 132 | 14 | 2 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-04 | 138 | 14 | 2 | 615822e542f12aa83df1561e262b8d72bdefc60e | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.42e-04 | 139 | 14 | 2 | 75cca1e6c1af289987d5d98455e9c6db81ecdd64 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.42e-04 | 139 | 14 | 2 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.42e-04 | 139 | 14 | 2 | 0ae117308bd10d3a7d2688794c69dc5a31cfca5f | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.42e-04 | 139 | 14 | 2 | fac6a3100a277efa1db250e0c576be1a0c901e6d | |
| ToppCell | Cerebellum-Hematopoietic|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.42e-04 | 139 | 14 | 2 | 3913c3828ad4cb5c71380519d0cf5f195e53c51d | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.42e-04 | 139 | 14 | 2 | de34e2f51f6fda638357abb662c111a20b83e70b | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.42e-04 | 139 | 14 | 2 | a077ce50f6d6746d80de35abed5b6dc35b1145b9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.66e-04 | 141 | 14 | 2 | 9f26b2a5ccdf8762f16b673e59543b694fbacc10 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-04 | 142 | 14 | 2 | bf4a9633d128805a0d7e426d6fe6c29db1ff8c81 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.90e-04 | 143 | 14 | 2 | 5d5ba2717126a0d4e4464f3604cb282cb977d5b2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.03e-04 | 144 | 14 | 2 | a9305d2499189f23b942775285be9fb260ce4214 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-04 | 145 | 14 | 2 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.28e-04 | 146 | 14 | 2 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-04 | 147 | 14 | 2 | 684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-04 | 147 | 14 | 2 | c031fad0a4e192019775809968e46da54a111d27 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.53e-04 | 148 | 14 | 2 | d3ea907f8f408e9bb97ed223a3089e403e35f911 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.53e-04 | 148 | 14 | 2 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-04 | 150 | 14 | 2 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.79e-04 | 150 | 14 | 2 | f4aed24b79e1be38abc7a1120256821601893d6d | |
| Drug | DMSe | 6.62e-05 | 132 | 14 | 3 | CID000020796 | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; HL60; HG-U133A | 1.45e-04 | 172 | 14 | 3 | 1381_UP | |
| Drug | R625 | 1.83e-04 | 33 | 14 | 2 | CID000072375 | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.07e-04 | 194 | 14 | 3 | 6066_UP | |
| Drug | sodium 4-phenylbutyrate; Up 200; 100uM; HL60; HG-U133A | 2.13e-04 | 196 | 14 | 3 | 363_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 2351_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | 2.20e-04 | 198 | 14 | 3 | 1553_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A | 2.20e-04 | 198 | 14 | 3 | 524_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3357_DN | |
| Drug | oligomycin; Up 200; 1uM; MCF7; HG-U133A | 2.23e-04 | 199 | 14 | 3 | 442_UP | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 5794_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A | 2.23e-04 | 199 | 14 | 3 | 1739_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A | 2.23e-04 | 199 | 14 | 3 | 1375_UP | |
| Drug | methylamine | 3.07e-04 | 222 | 14 | 3 | CID000006329 | |
| Drug | dioxamate | 6.09e-04 | 60 | 14 | 2 | CID000045285 | |
| Drug | 6-azauracil | 8.76e-04 | 72 | 14 | 2 | CID000068037 | |
| Drug | sodium azide | 1.22e-03 | 85 | 14 | 2 | CID000033557 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.09e-04 | 33 | 14 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | leptin measurement | 6.63e-04 | 81 | 14 | 2 | EFO_0005000 | |
| Disease | diet measurement | 1.19e-03 | 1049 | 14 | 4 | EFO_0008111 | |
| Disease | Abortion, Tubal | 1.20e-03 | 109 | 14 | 2 | C0000822 | |
| Disease | Early Pregnancy Loss | 1.20e-03 | 109 | 14 | 2 | C3830362 | |
| Disease | Miscarriage | 1.20e-03 | 109 | 14 | 2 | C4552766 | |
| Disease | Spontaneous abortion | 1.20e-03 | 109 | 14 | 2 | C0000786 | |
| Disease | serum IgG glycosylation measurement | 1.74e-03 | 523 | 14 | 3 | EFO_0005193 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.30e-03 | 152 | 14 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | age at menarche | 2.50e-03 | 594 | 14 | 3 | EFO_0004703 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLHNKTGWWFNECGL | 326 | Q86XS5 | |
| LNGLNWLAHSWCKGN | 486 | O14646 | |
| KEGSWWHCNSCSLKN | 1351 | P49792 | |
| WWADQNLAQLGTCSK | 1791 | Q9NZR2 | |
| GHWLGDNTAAWDQLK | 1521 | O43451 | |
| GLNWLAHSWCKNNSV | 491 | O14647 | |
| NESALWNCKHQGWGK | 231 | Q86VB7 | |
| WNCKHQGWGKHNCDH | 236 | Q86VB7 | |
| LHADKARGQQNWCWF | 91 | Q9UBY8 | |
| WDGSKRQCWQLGSNL | 141 | Q9BXN2 | |
| NCNCHLAWLGKWLRK | 666 | O75094 | |
| GWWYKNCHLANPNGR | 1231 | Q9UQP3 | |
| SLWNLHQGKQNGSAW | 1221 | O94964 | |
| GAWWYKNCHRTNLNG | 1296 | Q92752 | |
| SLCQNWRGWRKQSAG | 36 | A7E2V4 | |
| WHAWGMACLKAGNLT | 2066 | Q68DK2 |